Caseware UK (AP4) 2024.0.164 2024.0.164 2025-04-302025-04-30false2024-05-013trueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.3No description of principal activityfalsetrue 10380783 2024-05-01 2025-04-30 10380783 2023-05-01 2024-04-30 10380783 2025-04-30 10380783 2024-04-30 10380783 c:Director2 2024-05-01 2025-04-30 10380783 d:CurrentFinancialInstruments 2025-04-30 10380783 d:CurrentFinancialInstruments 2024-04-30 10380783 d:CurrentFinancialInstruments d:WithinOneYear 2025-04-30 10380783 d:CurrentFinancialInstruments d:WithinOneYear 2024-04-30 10380783 d:ShareCapital 2025-04-30 10380783 d:ShareCapital 2024-04-30 10380783 d:CapitalRedemptionReserve 2025-04-30 10380783 d:CapitalRedemptionReserve 2024-04-30 10380783 d:RetainedEarningsAccumulatedLosses 2025-04-30 10380783 d:RetainedEarningsAccumulatedLosses 2024-04-30 10380783 c:OrdinaryShareClass1 2024-05-01 2025-04-30 10380783 c:OrdinaryShareClass1 2025-04-30 10380783 c:OrdinaryShareClass1 2024-04-30 10380783 c:FRS102 2024-05-01 2025-04-30 10380783 c:AuditExempt-NoAccountantsReport 2024-05-01 2025-04-30 10380783 c:FullAccounts 2024-05-01 2025-04-30 10380783 c:PrivateLimitedCompanyLtd 2024-05-01 2025-04-30 10380783 6 2024-05-01 2025-04-30 10380783 e:PoundSterling 2024-05-01 2025-04-30 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 10380783









MIDLANDS MEDICAL PROPERTY LIMITED







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 30 APRIL 2025

 
MIDLANDS MEDICAL PROPERTY LIMITED
REGISTERED NUMBER: 10380783

BALANCE SHEET
AS AT 30 APRIL 2025

2025
2024
Note
£
£

Fixed assets
  

Investments
 4 
275,000
275,000

  
275,000
275,000

Current assets
  

Cash at bank and in hand
  
12,711
64,340

  
12,711
64,340

Creditors: amounts falling due within one year
 5 
(224,900)
(281,359)

Net current liabilities
  
 
 
(212,189)
 
 
(217,019)

Total assets less current liabilities
  
62,811
57,981

  

Net assets
  
62,811
57,981


Capital and reserves
  

Called up share capital 
 6 
1,400
1,400

Capital redemption reserve
  
1,000
1,000

Profit and loss account
  
60,411
55,581

  
62,811
57,981


The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 14 July 2025.



Page 1

 
MIDLANDS MEDICAL PROPERTY LIMITED
REGISTERED NUMBER: 10380783
    
BALANCE SHEET (CONTINUED)
AS AT 30 APRIL 2025



Dr S S Sangha
Director

The notes on pages 3 to 5 form part of these financial statements.

Page 2

 
MIDLANDS MEDICAL PROPERTY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2025

1.


General information

The Company is a private company, limited by shares, incorporated and domiciled in England within the United Kingdom, registration number 10380783.  The Company's registered office is Finance Dept, Eaton Wood Medical Centre, 1128 Tyburn Road, Birmingham, England, B24 0SY.                                                  
The financial statements are presented in sterling which is the functional currency of the company and the financial statements are rounded to the nearest £1.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

Cash flow
Under Financial Reporting Standard 102, the company is exempt from the requirement to prepare a cash flow statement on the grounds that it qualifies as a small company.

The following principal accounting policies have been applied:

 
2.2

Going concern

The company has net current liabilities of £212,189 as at 30 April 2025. The main short-term creditors of the company are the directors and shareholders who intend to continue supporting the company in the foreseeable future.  On this basis the director considers it appropriate to prepare the accounts on a going concern basis.

 
2.3

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Sale of goods

Revenue from the sale of goods is recognised when all of the following conditions are satisfied:
the Company has transferred the significant risks and rewards of ownership to the buyer;
the Company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold;
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the transaction; and
the costs incurred or to be incurred in respect of the transaction can be measured reliably.

 
2.4

Borrowing costs

All borrowing costs are recognised in profit or loss in the year in which they are incurred.

Page 3

 
MIDLANDS MEDICAL PROPERTY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2025

2.Accounting policies (continued)

 
2.5

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.


 
2.6

Valuation of investments

Investments in subsidiaries are measured at cost less accumulated impairment.

 
2.7

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.8

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.


3.


Employees

The average monthly number of employees, including directors, during the year was 3 (2024 - 3).


4.


Fixed asset investments





Other fixed asset investments

£



Cost or valuation


At 1 May 2024
275,000



At 30 April 2025
275,000




Page 4

 
MIDLANDS MEDICAL PROPERTY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2025

5.


Creditors: Amounts falling due within one year

2025
2024
£
£

Other loans
216,200
252,000

Corporation tax
1,133
915

Other taxation and social security
2,941
877

Accruals and deferred income
4,626
27,567

224,900
281,359



6.


Share capital

2025
2024
£
£
Allotted, called up and fully paid



140,000 (2024 - 140,000) Ordinary shares of £0.01 each
1,400
1,400





7.


Related party transactions

As at 30 April 2024 amounts of £216,200 (2024 - £252,000) was due to a partnership of which the directors and shareholders of the company are partners. The loan is interest free and repayable on demand. 

 
Page 5